Relation of Serum Vitamin D to Risk of Mitral Annular and Aortic Valve Calcium (from the Multi-Ethnic Study of Atherosclerosis).

[1]  Kay-Tee Khaw,et al.  Effect of Monthly High-Dose Vitamin D Supplementation on Cardiovascular Disease in the Vitamin D Assessment Study: A Randomized Clinical Trial , 2017, JAMA cardiology.

[2]  Chiadi E. Ndumele,et al.  Physical Activity, Vitamin D, and Incident Atherosclerotic Cardiovascular Disease in Whites and Blacks: The ARIC Study , 2017, The Journal of clinical endocrinology and metabolism.

[3]  L. Appel,et al.  Vitamin D, Calcium, and Cardiovascular Disease: A“D”vantageous or “D”etrimental? An Era of Uncertainty , 2017, Current Atherosclerosis Reports.

[4]  A. Reiner,et al.  Association of inflammatory, lipid and mineral markers with cardiac calcification in older adults , 2016, Heart.

[5]  A. Gupta,et al.  Mesa , 2016, Communications of the ACM.

[6]  E. Guallar,et al.  Factors Associated With Change in 25-Hydroxyvitamin D Levels Over Longitudinal Follow-Up in the ARIC Study. , 2016, The Journal of clinical endocrinology and metabolism.

[7]  M. Budoff,et al.  Serum phosphate is associated with aortic valve calcification in the Multi-ethnic Study of Atherosclerosis (MESA). , 2014, Atherosclerosis.

[8]  R. Kronmal,et al.  Risk factors associated with the incidence and progression of mitral annulus calcification: the multi-ethnic study of atherosclerosis. , 2013, American heart journal.

[9]  B. Kestenbaum,et al.  Racial differences in the association of serum 25-hydroxyvitamin D concentration with coronary heart disease events. , 2013, JAMA.

[10]  L. Borrell,et al.  The effect of body mass index on optimal vitamin D status in U.S. adults: the National Health and Nutrition Examination Survey 2001-2006. , 2013, Annals of epidemiology.

[11]  M. Budoff,et al.  Estimating mean annual 25-hydroxyvitamin D concentrations from single measurements: the Multi-Ethnic Study of Atherosclerosis. , 2013, The American journal of clinical nutrition.

[12]  J. Manson,et al.  Circulating 25-Hydroxy-Vitamin D and Risk of Cardiovascular Disease: A Meta-Analysis of Prospective Studies , 2012, Circulation. Cardiovascular quality and outcomes.

[13]  S. Wise,et al.  Development and certification of a standard reference material for vitamin D metabolites in human serum. , 2012, Analytical chemistry.

[14]  J. Manson,et al.  The VITamin D and OmegA-3 TriaL (VITAL): rationale and design of a large randomized controlled trial of vitamin D and marine omega-3 fatty acid supplements for the primary prevention of cancer and cardiovascular disease. , 2012, Contemporary clinical trials.

[15]  B. Kestenbaum,et al.  Seasonal variation in 25-hydroxyvitamin D concentrations in the cardiovascular health study. , 2011, American journal of epidemiology.

[16]  B. Kestenbaum,et al.  Association of serum phosphate levels with aortic valve sclerosis and annular calcification: the cardiovascular health study. , 2011, Journal of the American College of Cardiology.

[17]  R. Kronmal,et al.  Relation of mitral annular calcium and coronary calcium (from the Multi-Ethnic Study of Atherosclerosis [MESA]). , 2011, The American journal of cardiology.

[18]  JoAnn E. Manson,et al.  The 2011 Report on Dietary Reference Intakes for Calcium and Vitamin D from the Institute of Medicine: What Clinicians Need to Know , 2010, The Journal of clinical endocrinology and metabolism.

[19]  M. Bissell.  25-Hydroxyvitamin D Levels Inversely Associate with Risk for Developing Coronary Artery Calcification , 2011 .

[20]  L. Stevens,et al.  Estimating GFR using the CKD Epidemiology Collaboration (CKD-EPI) creatinine equation: more accurate GFR estimates, lower CKD prevalence estimates, and better risk predictions. , 2010, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[21]  J. J. Rivera,et al.  Relationships of mitral annular calcification to cardiovascular risk factors: the Multi-Ethnic Study of Atherosclerosis (MESA). , 2010, Atherosclerosis.

[22]  B. Kestenbaum,et al.  25-hydroxyvitamin D levels inversely associate with risk for developing coronary artery calcification. , 2009, Journal of the American Society of Nephrology : JASN.

[23]  K. Weber,et al.  Hypovitaminosis D and Valvular Calcification in Patients With Dilated Cardiomyopathy , 2009, The American journal of the medical sciences.

[24]  B. Kestenbaum,et al.  Association of serum phosphate with vascular and valvular calcification in moderate CKD. , 2009, Journal of the American Society of Nephrology : JASN.

[25]  R. Koerfer,et al.  Vitamin D and vascular calcification , 2007, Current opinion in lipidology.

[26]  R. Kronmal,et al.  Reproducibility of CT measurements of aortic valve calcification, mitral annulus calcification, and aortic wall calcification in the multi-ethnic study of atherosclerosis. , 2006, Academic radiology.

[27]  A. Tajik,et al.  Human Aortic Valve Calcification Is Associated With an Osteoblast Phenotype , 2003, Circulation.

[28]  R. Kronmal,et al.  Multi-Ethnic Study of Atherosclerosis: objectives and design. , 2002, American journal of epidemiology.

[29]  Sílvia Ribeiro,et al.  Cardiac valve calcification in haemodialysis patients: role of calcium-phosphate metabolism. , 1998, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[30]  J. Lemire.  Immunomodulatory role of 1,25‐dihydroxyvitamin D3 , 1992, Journal of cellular biochemistry.

[31]  R. Detrano,et al.  Quantification of coronary artery calcium using ultrafast computed tomography. , 1990, Journal of the American College of Cardiology.